Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong province

Chinese Journal of Cancer

Volumn 28, Issue 1, 2009, Pages 57-59

  Ling, Wei ^a   Cao, Su Mei ^b,c   Huang, Qi Hong ^a   Li, Yan Hua ^a   Deng, Man Quan ^b,c  

^a Sihui Cancer Institute   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Epstein Barr virus; Nasopharyngeal neoplasm; Prognosis; VCA IgA

Indexed keywords

IMMUNOGLOBULIN A; VIRUS CAPSID ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHINA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; CHINA; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 67651250042     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Min HQ, Huang TB. Prospective observation on correlation between EB virus and nasopharyngeal carcinoma (NPC) [J]. Aizheng, 1991,10(5):367-370. [in Chinese]
2. Huang TB. High risk population, precancerous changes and early detection for nasopharyngeal carcinoma [J]. Bull Chin Cancer, 1996,5(5):9. [in Chinese]
3. Twu CW, Wang WY, Liang WM, et al. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma [J]. Int J Radiat Oncol Biol Phys, 2007,67(1):130-137.
4. Old LJ, Boyse EA, Oettgen HF, et al. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells [J]. Proc Natl Acad Sci USA, 1966,56(6):1699-1704.
5. Huang TB. The advance for early detection of nasopharyngeal carcinoma [J]. Chin J Otorhinolaryngol, 1997,32(6):369-371. [in Chinese]
6. Zeng Y, Zhang LG, Wu YC, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China [J]. Int J Cancer, 1985,36(5):545-547.
7. Zeng MS, Wang HM, Chen J, et al. Study on the expression of EBERs in nasopharyngeal carcinoma tumorgenesis [J]. Aizheng, 1996,15(1):4-7. [in Chinese]
8. Okano M, Taguchi Y, Nakamine H, et al. Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice [J]. Am J Pathol, 1990,137(3):517-22.
9. Liu MT, Yeh CY. Prognostic value of anti-Epstain-Barr virus antibodies in nasopharyngeal carcinoma [J]. Radiat Med, 1998,16(2):113-117.
10. Liu MZ, Guan XX, Gao JM, et al. Relationship between EB virus VCA-IgA antibody and long-term cure of nasopharyngeal carcinoma [J]. Aizheng, 1998,17(5):365-367. [in Chinese]
11. Ho S, Teo P, Kwan WH, et al. Staging and IgA VCA titre in patients with nasopharyngeal carcinoma: changes over a 12-year period [J]. Oral Oncol, 1998,34(6):491-495.